4
Changes in Ownership
Pacira BioSciences, Inc. Filed Acc 0001209191-23-023336
Director sold 7,000 shares at $40.72 ($285,040)
- Director acquired 7,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Brege Laura Director | 2023-04-03 | Option exercise 10b5-1 | +7,000 | $29.90 | $209,300 | 17,147 | D |
| Brege Laura Director | 2023-04-03 | Sale 10b5-1 | −7,000 | $40.72 | $285,040 | 10,147 | D |
| Derivatives | |||||||
| Brege Laura Director | 2023-04-03 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −7,000 | 0 | D | ||
| Open-market sales · 7,000 sh · avg $40.72 · $285,040 | |||||||
Loading xslF345X04/doc4.xml…